Skip to main content
OpenTrials
Completed

NCT Number: NCT06724068

Diabetes, Insulin Resistance and Body Composition

The goal of this retrospective study is to learn about the correlation between diabetes, insulin resistance and body compositions.

The main question[s] it aims to answer are:

* [The difference of body composition between the individuals of insulin resistance and diabetes] * [The effect of diabetes on body composition]

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

The First Affiliated Hospital of Shandong First Medical University

Jinan, Shandong, 250000, China

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years and older.
  • Diagnosed with type 2 diabetes mellitus according to recognized diagnostic criteria.
  • Availability of complete body composition data (e.g., DXA measurements).
  • Documented HbA1c levels and other glycemic control data.
  • Continuous medical records available during the study period

Exclusion criteria

  • Presence of other severe metabolic diseases, such as liver failure or kidney failure.
  • Use of medications affecting muscle mass (e.g., glucocorticoids) for more than three months.
  • History of malignancy or ongoing treatment for cancer.
  • Missing critical research data (e.g., diabetes duration or HbA1c levels).
  • History of surgeries causing significant body composition changes (e.g., bariatric surgery).

Treatment and study plan

Diabetes,Insulin resistance,Control

Other

This retrospective study uses medical records and diagnostic data from patients with type 2 diabetes and healthy controls obtained from Qianfoshan Hospital from2019 to 2022

Primary outcomes

  1. Prevalence of Sarcopenia in Diabetic Patients

    Time frame: Retrospective analysis of data collected between2019 and 2022

    The proportion of diabetic patients diagnosed with sarcopenia, assessed based on measurements of muscle mass, muscle strength, and physical performance. Sarcopenia will be defined according to AWGS 2019 and EWGSOP2

Sponsors and collaborators

Lead sponsor

Xuan Song

Other

Registry information

Official study title

The Correlation Between Diabetes, Insulin Resistance and Body Composition

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Dec 9, 2024
Registry last updated
Dec 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.